This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.
Approval for implementation of system software 06-04 on the cobas e 602 to address a software limitation
Device | Elecsys Anti-HCV Immunoassay |
Classification Name | Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus |
Generic Name | Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus |
Applicant | ROCHE DIAGNOSTICS CORP. |
Date Received | 2017-10-11 |
Decision Date | 2017-12-20 |
PMA | P090009 |
Supplement | S017 |
Product Code | MZO |
Docket Number | Premarket Approval (PMA) // Quick Links: Skip To Main Page Content Skip To Search Skip To Topics Menu Skip To Common Links U.S. Food & Drug Administration Follow FDA En Español Search FDA Home Food Drugs Medical Devices Radia |
Advisory Committee | Microbiology |
Supplement Type | Real-time Process |
Supplement Reason | Change Design/components/specifications/material |
Expedited Review | No |
Combination Product | No |
Applicant Address | ROCHE DIAGNOSTICS CORP. 9115 Hague Rd. indianapolis, IN 46250 |
Supplement Number | Date | Supplement Type |
---|---|---|
P090009 | Original Filing | |
S018 | 2018-10-26 | Normal 180 Day Track No User Fee |
S017 | 2017-10-11 | Real-time Process |
S016 | 2017-08-03 | 30-day Notice |
S015 | 2016-02-16 | 30-day Notice |
S014 | 2016-01-27 | 30-day Notice |
S013 | 2015-10-07 | 30-day Notice |
S012 | 2014-08-22 | 30-day Notice |
S011 | 2012-11-30 | 30-day Notice |
S010 | 2012-09-05 | 30-day Notice |
S009 | ||
S008 | 2012-02-29 | 30-day Notice |
S007 | 2012-01-31 | 135 Review Track For 30-day Notice |
S006 | 2011-11-21 | 30-day Notice |
S005 | 2011-08-29 | 135 Review Track For 30-day Notice |
S004 | 2011-08-17 | 135 Review Track For 30-day Notice |
S003 | 2011-05-17 | Normal 180 Day Track No User Fee |
S002 | 2011-04-11 | 30-day Notice |
S001 | 2010-07-28 | Normal 180 Day Track |